What is Seratopical?
Seratopical, operating under the umbrella of Sera Labs, functions as a premier health and wellness entity dedicated to the synthesis of natural ingredients and scientific rigor. The company distinguishes itself through the Seratopical Revolution skincare line, which utilizes plant-based formulations designed for deep dermal penetration. Beyond skincare, the firm has diversified its portfolio with Nutri-Strips, a proprietary delivery system for wellness supplements. By bridging the gap between holistic health and clinical efficacy, Seratopical addresses the growing consumer demand for clean-label, science-backed health solutions that cater to modern lifestyle challenges.
How much funding has Seratopical raised?
Seratopical has raised a total of $5M across 1 funding round:
Other Financing Round
$5M
Other Financing Round (2019): $5M, investors not publicly disclosed
Key Investors in Seratopical
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Seratopical?
With this major enterprise-level funding, Seratopical is poised to transition into a phase of aggressive operational scaling and product diversification. The strategic allocation of this capital will likely focus on expanding distribution channels, enhancing research and development for its Nutri-Strips technology, and strengthening its brand presence in the global wellness market. As the company matures, the focus will shift toward optimizing supply chain efficiencies and exploring new therapeutic applications for its plant-based formulations, ensuring sustained growth and long-term value creation for stakeholders in the health-tech and consumer goods sectors.
See full Seratopical company page
